Study finds missed opportunities with COVID antivirals on Australian Pharmaceutical Benefits Scheme
A new study has revealed significant discrepancies in the prescription of COVID-19 antivirals, indicating that many patients may not have received the most effective treatment available.
Jul 11, 2024
0
0